Edward Barker

3.7k total citations
58 papers, 2.8k citations indexed

About

Edward Barker is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Edward Barker has authored 58 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 31 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Edward Barker's work include Immune Cell Function and Interaction (39 papers), HIV Research and Treatment (31 papers) and T-cell and B-cell Immunology (15 papers). Edward Barker is often cited by papers focused on Immune Cell Function and Interaction (39 papers), HIV Research and Treatment (31 papers) and T-cell and B-cell Immunology (15 papers). Edward Barker collaborates with scholars based in United States, Italy and United Kingdom. Edward Barker's co-authors include Carl E. Mackewicz, Matthew Bonaparte, Jay A. Levy, Jay A. Levy, Jeffrey P. Ward, Vicente Planelles, Ralph A. Reisfeld, Zachary Davis, Domenico Mavilio and Katharine N. Bossart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Edward Barker

58 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Barker United States 30 1.9k 1.5k 563 446 385 58 2.8k
Monica Vaccari United States 23 1.4k 0.7× 1.1k 0.7× 360 0.6× 358 0.8× 217 0.6× 42 2.0k
Alison C. Mawle United States 13 1.1k 0.6× 1.5k 1.0× 502 0.9× 731 1.6× 323 0.8× 29 2.3k
Jakob Nilsson Switzerland 23 1.2k 0.6× 642 0.4× 298 0.5× 532 1.2× 269 0.7× 63 2.2k
R. N. Boswell United States 27 1.3k 0.7× 2.1k 1.4× 755 1.3× 1.1k 2.4× 437 1.1× 49 3.2k
Rachel Schrier United States 27 1.1k 0.6× 1.8k 1.2× 1.9k 3.3× 870 2.0× 340 0.9× 55 3.6k
Susan M. Kramer United States 14 901 0.5× 791 0.5× 349 0.6× 516 1.2× 450 1.2× 26 2.1k
Marta Massanella Spain 29 737 0.4× 1.7k 1.1× 633 1.1× 1.1k 2.5× 343 0.9× 79 2.4k
Ann Chahroudi United States 29 1.6k 0.8× 1.5k 1.0× 999 1.8× 1.0k 2.3× 424 1.1× 101 3.3k
Jean‐Philippe Herbeuval France 23 1.5k 0.8× 835 0.5× 382 0.7× 307 0.7× 390 1.0× 55 2.3k
Thomas M. McHugh United States 22 806 0.4× 816 0.5× 482 0.9× 489 1.1× 240 0.6× 36 2.1k

Countries citing papers authored by Edward Barker

Since Specialization
Citations

This map shows the geographic impact of Edward Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Barker more than expected).

Fields of papers citing papers by Edward Barker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Barker. The network helps show where Edward Barker may publish in the future.

Co-authorship network of co-authors of Edward Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Barker. A scholar is included among the top collaborators of Edward Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Barker. Edward Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuzel, Timothy M., Jeffrey R. Schneider, Edward Barker, et al.. (2024). Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia. International Journal of Molecular Sciences. 25(17). 9448–9448. 10 indexed citations
2.
Cogswell, Andrew C., et al.. (2022). Contribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4 + T Cells During Acute and Chronic SIV Infection of the Colon. AIDS Research and Human Retroviruses. 38(9). 709–725. 1 indexed citations
3.
Davis, Zachary, et al.. (2016). CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells. AIDS Research and Human Retroviruses. 33(2). 93–100. 20 indexed citations
4.
Davis, Zachary, Andrew C. Cogswell, Julie Boucau, et al.. (2016). A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells. PLoS Pathogens. 12(2). e1005421–e1005421. 60 indexed citations
5.
DePaula-Silva, Ana Beatriz, et al.. (2015). HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins. Retrovirology. 12(1). 65–65. 22 indexed citations
6.
DePaula-Silva, Ana Beatriz, et al.. (2014). Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx. Virology. 476. 19–25. 8 indexed citations
7.
Famiglietti, Marylinda, Ana Beatriz DePaula-Silva, Christopher K. Rodesch, et al.. (2014). Downmodulation of CCR7 by HIV-1 Vpu Results in Impaired Migration and Chemotactic Signaling within CD4+ T Cells. Cell Reports. 7(6). 2019–2030. 49 indexed citations
8.
Dillon, Stephanie M., et al.. (2013). The Natural Killer Cell Interferon-Gamma Response to Bacteria Is Diminished in Untreated HIV-1 Infection and Defects Persist Despite Viral Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3). 259–267. 24 indexed citations
9.
Davis, Zachary, Jeffrey P. Ward, & Edward Barker. (2011). Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays. Journal of Visualized Experiments. 11 indexed citations
10.
Shah, Ankur H., Zachary Davis, Jeffrey P. Ward, et al.. (2010). Degranulation of Natural Killer Cells Following Interaction with HIV-1-Infected Cells Is Hindered by Downmodulation of NTB-A by Vpu. Cell Host & Microbe. 8(5). 397–409. 144 indexed citations
11.
Ward, Jeffrey P., Zachary Davis, Jason L. DeHart, et al.. (2009). HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response. PLoS Pathogens. 5(10). e1000613–e1000613. 118 indexed citations
12.
Fogli, Manuela, Domenico Mavilio, Enrico Brunetta, et al.. (2008). Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals. PLoS Pathogens. 4(7). e1000101–e1000101. 98 indexed citations
13.
14.
Ward, Jeffrey P., Matthew Bonaparte, & Edward Barker. (2004). HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts. AIDS. 18(13). 1769–1779. 55 indexed citations
15.
Bonaparte, Matthew & Edward Barker. (2003). Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS. 17(4). 487–494. 62 indexed citations
16.
Wrzesinski, Stephen H., Rosanne Séguin, Yingxian Liu, et al.. (2000). HTLV Type 1 Tax Transduction in Microglial Cells and Astrocytes by Lentiviral Vectors. AIDS Research and Human Retroviruses. 16(16). 1771–1776. 18 indexed citations
17.
Greco, Giampaolo, Edward Barker, & Jay A. Levy. (1998). Differences in HIV Replication in CD4 + Lymphocytes Are Not Related to β-Chemokine Production. AIDS Research and Human Retroviruses. 14(16). 1407–1411. 13 indexed citations
18.
Mackewicz, Carl E., Edward Barker, Giampaolo Greco, Gustavo Reyes‐Terán, & Jay A. Levy. (1997). Do beta-chemokines have clinical relevance in HIV infection?. Journal of Clinical Investigation. 100(4). 921–930. 63 indexed citations
19.
Blackbourn, David J., Carl E. Mackewicz, Edward Barker, & Jay A. Levy. (1994). Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine. Research in Immunology. 145(8-9). 653–659. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Vaccari Breakdown of academic impact, for papers by Alison C. Mawle Breakdown of academic impact, for papers by Jakob Nilsson Breakdown of academic impact, for papers by R. N. Boswell Breakdown of academic impact, for papers by Rachel Schrier Breakdown of academic impact, for papers by Susan M. Kramer Breakdown of academic impact, for papers by Marta Massanella Breakdown of academic impact, for papers by Ann Chahroudi Breakdown of academic impact, for papers by Jean‐Philippe Herbeuval Breakdown of academic impact, for papers by Thomas M. McHugh
Rankless by CCL
2026